Shareholders at the United Drug extraordinary general meeting today passed all resolutions relating to the split in the companies shares.
Earlier this week United Drug acquired Mantis Surgical, a UK medical equipment and devices suppliers and distributors.
Consideration for the acquisition is £5.575m in cash, payable on completion, with an additional consideration of up to £1.3m, payable on achievement of agreed profit targets for the 12 months beginning 1 July 2003.
Mantis has 17 employees and has exclusive distribution agreements in the UK with a number of leading international medical manufacturers.
